Bismuth Subcitrate

DRUG5 trials

Sponsors

European Organisation for Research and Treatment of Cancer - EORTC, University of Bari, University Medical Centre Ljubljana, National Institute of Public Health, Slovenia, University of Medicine and Pharmacy at Ho Chi Minh City

Conditions

Antibiotic Resistant InfectionAntibiotic Resistant StrainHelicobacter Pylori InfectionLymphoma

Phase 2

Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma

CompletedNCT00003151

European Organisation for Research and Treatment of Cancer - EORTCLymphoma

Start: 1997-09-30Target: 96Updated: 2012-07-02

Phase 3

Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection.

University of BariHelicobacter Pylori Infection, Antibiotic Resistant Infection, Antibiotic Resistant Strain

Start: 2020-01-14End: 2022-04-14Target: 362Updated: 2021-01-12

Phase 4

Bismuth Quadruple Therapy Versus Standard Triple Therapy

University Medical Centre LjubljanaHelicobacter Pylori Infection

Start: 2022-03-03End: 2025-11-03Target: 216Updated: 2023-11-22

Unknown Phase

Feasibility Study of the Proposed Test-and-treat Screening Program in Younger Participants With H. Pylori Infection

Enrolling by invitationNCT06216639

National Institute of Public Health, SloveniaHelicobacter Pylori Infection

Start: 2024-02-01End: 2025-01-31Target: 2000Updated: 2024-02-09

Metronidazole- Versus Tinidazole-Based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication

Not yet recruitingNCT07746934

University of Medicine and Pharmacy at Ho Chi Minh CityHelicobacter Pylori Infection

Start: 2026-07-27End: 2027-12-27Target: 600Updated: 2026-08-05